HCPCS Level IIsuppliesActive
A9542
In111 ibritumomab, dx
BETOS: I1E
Effective: 2025-01-01
Description
Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
$0.00
Non-Facility Price
$0.00
Facility Price
0.00
Work RVU
0.00
Total RVU (Non-Fac)
XXX
Global Days
Carrier Priced
Status